FindTrial
Sign In

Discovery of new biomarkers related with disease progression in hardly curable malignant hematologic diseases

Discovery of new biomarkers related with disease progression by GWAS (Genome-wide-association-study) analysis in hardly curable malignant hematologic diseases

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0000414
Enrollment
200
Registered
2012-04-23
Start date
2012-03-17
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Seoul National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Bone marrow and saliva obtained from patients, who make diagnose with hardly curable malignant hematologic disese in Seoul National University Hospital

Exclusion criteria

Exclusion criteria: patients do not sign in informed consent

Design outcomes

Primary

MeasureTime frame
somatic muation and de novo mutation—

Secondary

MeasureTime frame
Death ;Relapse;Response of chemotherapy—

Countries

Korea, Republic of

Contacts

Public ContactKwang-Sung Ahn

Seoul National University Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026